Research programme: NMDA receptor antagonists - Gedeon RichterAlternative Names: N-methyl-D-aspartate receptor agonists - Gedeon Richter
Latest Information Update: 26 Jul 2010
At a glance
- Originator Gedeon Richter
- Mechanism of Action NMDA receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Neuropathic pain; Pain
Most Recent Events
- 26 Jul 2010 Preclinical development is ongoing in Hungary